279 related articles for article (PubMed ID: 18326020)
41. Expression profile of the polycomb group protein enhancer of Zeste homologue 2 and its prognostic relevance in renal cell carcinoma.
Hinz S; Weikert S; Magheli A; Hoffmann M; Engers R; Miller K; Kempkensteffen C
J Urol; 2009 Dec; 182(6):2920-5. PubMed ID: 19846140
[TBL] [Abstract][Full Text] [Related]
42. Deregulated expression of p16INK4a and p53 pathway members in benign and malignant myoepithelial tumours of the salivary glands.
Vékony H; Röser K; Löning T; Raaphorst FM; Leemans CR; Van der Waal I; Bloemena E
Histopathology; 2008 Dec; 53(6):658-66. PubMed ID: 19076682
[TBL] [Abstract][Full Text] [Related]
43. Prognostic impact of molecular analyses in adenoid cystic carcinomas of the salivary gland.
Preisegger KH; Beham A; Kopp S; Jessernigg G; Gugl A; Stammberger H
Onkologie; 2001 Jun; 24(3):273-7. PubMed ID: 11455221
[TBL] [Abstract][Full Text] [Related]
44. Management of adenoid cystic carcinoma of minor salivary glands.
Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Koufogiannis D
J Oral Maxillofac Surg; 2006 Jul; 64(7):1114-20. PubMed ID: 16781345
[TBL] [Abstract][Full Text] [Related]
45. Assessment of p16 expression and HPV infection in adenoid cystic carcinoma of the lacrimal gland.
Wang Y; Tian Y; Lin J; Chen L; Wang L; Hao P; Han R; Ying M; Li X; Tang X
Mol Vis; 2018; 24():143-152. PubMed ID: 29430168
[TBL] [Abstract][Full Text] [Related]
46. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland.
Bell D; Ferrarotto R; Fox MD; Roberts D; Hanna EY; Weber RS; El-Naggar AK
Cancer Biol Ther; 2015; 16(6):834-8. PubMed ID: 25923130
[TBL] [Abstract][Full Text] [Related]
47. Expression of RUNX3 in salivary adenoid cystic carcinoma: implications for tumor progression and prognosis.
He JF; Ge MH; Zhu X; Chen C; Tan Z; Li YN; Gu ZY
Cancer Sci; 2008 Jul; 99(7):1334-40. PubMed ID: 18410404
[TBL] [Abstract][Full Text] [Related]
48. Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis.
Yang X; Dai J; Li T; Zhang P; Ma Q; Li Y; Zhou J; Lei D
Oral Oncol; 2010 Oct; 46(10):755-60. PubMed ID: 20850374
[TBL] [Abstract][Full Text] [Related]
49. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.
Bachmann IM; Halvorsen OJ; Collett K; Stefansson IM; Straume O; Haukaas SA; Salvesen HB; Otte AP; Akslen LA
J Clin Oncol; 2006 Jan; 24(2):268-73. PubMed ID: 16330673
[TBL] [Abstract][Full Text] [Related]
50. MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.
Fujii K; Murase T; Beppu S; Saida K; Takino H; Masaki A; Ijichi K; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Inagaki H
Histopathology; 2017 Nov; 71(5):823-834. PubMed ID: 28594149
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical analysis of polycomb group protein expression in advanced gastric cancer.
Lee H; Yoon SO; Jeong WY; Kim HK; Kim A; Kim BH
Hum Pathol; 2012 Oct; 43(10):1704-10. PubMed ID: 22520951
[TBL] [Abstract][Full Text] [Related]
52. Expression and importance of zinc-finger transcription factor Slug in adenoid cystic carcinoma of salivary gland.
Tang Y; Liang X; Zhu G; Zheng M; Yang J; Chen Y
J Oral Pathol Med; 2010 Nov; 39(10):775-80. PubMed ID: 20738754
[TBL] [Abstract][Full Text] [Related]
53. Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis.
Breuer RH; Snijders PJ; Smit EF; Sutedja TG; Sewalt RG; Otte AP; van Kemenade FJ; Postmus PE; Meijer CJ; Raaphorst FM
Neoplasia; 2004; 6(6):736-43. PubMed ID: 15720799
[TBL] [Abstract][Full Text] [Related]
54. Expression of transforming growth factor-alpha in adenoid cystic carcinoma of the salivary gland.
Chiang CP; Chen CH; Liu BY; Sun A; Leu JS; Wang JT
J Formos Med Assoc; 2001 Jul; 100(7):471-7. PubMed ID: 11579613
[TBL] [Abstract][Full Text] [Related]
55. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL
Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346
[TBL] [Abstract][Full Text] [Related]
56. Metallothionein immunostaining in adenoid cystic carcinomas of the salivary glands.
Alves SM; Cardoso SV; de Fátima Bernardes V; Machado VC; Mesquita RA; Vieira do Carmo MA; Ferreira Aguiar MC
Oral Oncol; 2007 Mar; 43(3):252-6. PubMed ID: 16857408
[TBL] [Abstract][Full Text] [Related]
57. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
58. Immunohistochemical evaluation of estrogen and progesterone receptors in adenoid cystic carcinoma of salivary gland origin.
Dori S; Trougouboff P; David R; Buchner A
Oral Oncol; 2000 Sep; 36(5):450-3. PubMed ID: 10964052
[TBL] [Abstract][Full Text] [Related]
59. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
